Related Experiment Video
Updated: Feb 27, 2026
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
Antiglioma pseurotin A from marine Bacillus sp. FS8D regulating tumour metabolic enzymes
Komal Anjum1, Hongyun Bi2, Weiyun Chai1
1a Ocean College, Zhoushan Campus , Zhejiang University , Zhoushan , China.
Abstract:
Pseurotin A was isolated from a culture of marine Bacillus sp. FS8D and showed to be active against the proliferation of four different glioma cells with IC50 values of 0.51-29.3 μM. It has been found that pseurotin A downregulated the expression of tumour glycolytic enzymes pyruvate kinase M2 (PKM2) and lactate dehydrogenase 5 (LDH5) and upregulated the expression of pyruvate dehydrogenase beta (PDHB), adenosine triphosphate synthase beta (ATPB) and cytochrome C (Cyto-C), the important regulators for tricarboxylic acid cycle and oxidative phosphorylation. The data suggested that targeting multiple metabolic enzymes might be one of the antiglioma mechanisms of pseurotin A.
Insights
Marine Bacillus sp. FS8D yielded Pseurotin A, an active compound against glioma cells. This compound targets key metabolic enzymes involved in tumor glycolysis and cellular respiration.
Area of Science:
- Marine microbiology
- Cancer biology
- Metabolomics
Background:
- Glioma is a primary brain tumor with limited treatment options.
- Metabolic reprogramming is a hallmark of cancer, including glioma.
- Pseurotin A is a natural product with potential therapeutic applications.
Purpose of the Study:
- To investigate the anti-glioma activity of Pseurotin A.
- To elucidate the molecular mechanisms underlying Pseurotin A's anti-glioma effects.
- To explore Pseurotin A as a potential therapeutic agent for glioma.
Main Methods:
- Isolation and characterization of Pseurotin A from marine Bacillus sp. FS8D.
- In vitro assessment of Pseurotin A's antiproliferative activity against human glioma cell lines.
- Analysis of key metabolic enzyme expression levels (PKM2, LDH5, PDHB, ATPB, Cyto-C) using molecular biology techniques.
Main Results:
- Pseurotin A exhibited significant antiproliferative effects against four human glioma cell lines (IC50 values ranging from 0.51-29.3 μM).
- Pseurotin A downregulated tumor glycolytic enzymes pyruvate kinase M2 (PKM2) and lactate dehydrogenase 5 (LDH5).
- Pseurotin A upregulated enzymes crucial for the tricarboxylic acid cycle and oxidative phosphorylation, including pyruvate dehydrogenase beta (PDHB), adenosine triphosphate synthase beta (ATPB), and cytochrome C (Cyto-C).
Conclusions:
- Pseurotin A demonstrates potent anti-glioma activity.
- The anti-glioma mechanism of Pseurotin A involves the modulation of key metabolic enzymes.
- Targeting multiple metabolic pathways simultaneously represents a promising strategy for glioma treatment.
